Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Nambiar · SciRah

Researcher profile · Semantic Scholar

A. Nambiar

Share profile

A. Nambiar — researcher profile on SciRah

h-index: 17
Works: 62
Citations: 3,159

Most-cited papers

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
J. Justice, A. Nambiar, T. Tchkonia, N. LeBrasseur +7 more
2019EBioMedicine1,157 citations Open access
Semantic Scholar
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
V. Cottin, N. Hirani, D. Hotchkin, A. Nambiar +7 more
2018European Respiratory Review569 citations Open access
Semantic Scholar
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
A. Wells, K. Flaherty, K. Brown, Y. Inoue +164 more
2020The Lancet Respiratory Medicine449 citations
Semantic Scholar
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
A. Nambiar, Dean Kellogg, J. Justice, M. Goros +11 more
2023EBioMedicine270 citations Open access
Semantic Scholar
Pulmonary Function Measures Predict Mortality Differently in Idiopathic Pulmonary Fibrosis versus Combined Pulmonary Fibrosis and Emphysema
S. Schmidt, A. Nambiar, N. Tayob, Baskaran Sundaram +10 more
2010European Respiratory Journal158 citations Open access
Semantic Scholar
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection
S. Ahuja, M. Manoharan, Grace C. Lee, L. Mckinnon +168 more
2023Nature Communications87 citations Open access
Semantic Scholar
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
Yi Zhu, Larissa P. G. Langhi Prata, Erin O. Wissler-Gerdes, J. Netto +19 more
2022EBioMedicine78 citations Open access
Semantic Scholar
Cellular Senescence in Idiopathic Pulmonary Fibrosis
D. L. Kellogg, D. L. Kellogg, N. Musi, A. Nambiar
2021Current Molecular Biology Reports61 citations Open access
Semantic Scholar
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
F. Martinez, E. Yow, K. Flaherty, L. Snyder +14 more
2021Journal of the American Medical Association (JAMA)59 citations Open access
Semantic Scholar
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
F. Amati, A. Stainer, M. Mantero, A. Gramegna +10 more
2022International Journal of Molecular Sciences37 citations Open access
Semantic Scholar
Possible UIP Pattern on High-Resolution Computed Tomography is Associated with Better Survival than Definite UIP in IPF Patients
M. Salisbury, L. Tolle, Meng Xia, S. Murray +11 more
2017Respiratory Medicine36 citations Open access
Semantic Scholar
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
A. Podolanczuk, J. S. Kim, C. Cooper, J. Lasky +72 more
2022BMC Pulmonary Medicine32 citations Open access
Semantic Scholar
The role of precision medicine in interstitial lung disease
Toby M. Maher, A. Nambiar, A. Wells
2022European Respiratory Journal31 citations Open access
Semantic Scholar
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
D. Maselli, J. F. Fernandez, Christine Y Whong, K. Echevarria +3 more
2012Infection and Drug Resistance20 citations Open access
Semantic Scholar
Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians
A. Nambiar, Christopher M. Walker, J. Sparks
2021Therapeutic Advances in Respiratory Disease19 citations Open access
Semantic Scholar
Essential Components of an Interstitial Lung Disease Clinic
B. Graney, C. He, M. Marll, S. Matson +55 more
2020Chest19 citations Open access
Semantic Scholar
Potential of phosphodiesterase 4B inhibition in the treatment of progressive pulmonary fibrosis
R. Keith, A. Nambiar
2025Therapeutic Advances in Respiratory Disease17 citations
Semantic Scholar
Diagnosis and Management of Sarcoidosis.
Natalia Soto-Gomez, J. Peters, A. Nambiar
2016American Family Physician17 citations
Semantic Scholar
Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
A. Nambiar, A. Anzueto, J. Peters
2017PLoS ONE12 citations Open access
Semantic Scholar
Senolytics in Idiopathic Pulmonary Fibrosis: Preliminary Results from a First-in-Human, Open-Label, Pilot Study
A. Nambiar, J. Justice, R. Pascual, Shahrukh K Hashmi +5 more
2019B17. ADVANCES IN ILD THERAPY9 citations
Semantic Scholar
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
Gabriele Bongiovanni, A. Tonutti, A. Stainer, Mattia Nigro +8 more
2024BMJ Open Respiratory Research5 citations Open access
Semantic Scholar
Combination pirfenidone and inhaled N‐acetylcysteine therapy for IPF: Does it take these two to tango?
Maria I. Velez, A. Nambiar
2015Respirology (Carlton South. Print)5 citations
Semantic Scholar
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion
F. Amati, Dean L. Kellogg, Marcos I. Restrepo, F. Blasi +2 more
2025Therapeutic Advances in Respiratory Disease3 citations Open access
Semantic Scholar
Procalcitonin in acute exacerbations of interstitial pneumonia: Another tool in the toolbox?
A. Nambiar
2013Respirology (Carlton South. Print)3 citations Open access
Semantic Scholar
Caring for Rural Patients With Interstitial Lung Disease
A. DeDent, J. Shore, Rebecca Bascom, J. Reichuber +7 more
2025CHEST pulmonary2 citations Open access
Semantic Scholar
A Low Forced Vital Capacity (FVC)/Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) Ratio Increases Clinical Suspicion for Fibrotic Hypersensitivity Pneumonitis (FHP) Over Idiopathic Pulmonary Fibrosis (IPF)
T.S. Vongvivitpatana, A. Nambiar
2024Cureus2 citations Open access
Semantic Scholar
Post hoc pooled analyses of open-label and randomized controlled trials of senolytics dasatinib and quercetin in Idiopathic Pulmonary Fibrosis
Dean L. Kellogg, A. Nambiar, J. Justice, M. Goros +11 more
2023Idiopathic interstitial pneumonias2 citations
Semantic Scholar
Acute Lower Gastrointestinal Bleeding
Jose Castaneda-Nerio, A. Nambiar
2020Evidence-Based Critical Care2 citations
Semantic Scholar
Diagnosis and Management of Thrombotic Thrombocytopenic Purpura
Bravein Amalakuhan, A. Nambiar
2017Evidence-Based Critical Care2 citations
Semantic Scholar
DIAGNOSTIC TRAJECTORIES OF INTERSTITIAL LUNG DISEASE AFTER IMPLEMENTATION OF A MULTIDISCIPLINARY DISCUSSION TEAM MEETING
F. Amati, M. I. Restrepo, S. Aliberti, F. Blasi +1 more
2020Chest1 citations Open access
Semantic Scholar
Hypersensitivity Pneumonitis (Including Environmental Assessment): Diagnosis and Management
W. Tam, Tasnim Islam, A. Nambiar
2019Current Pulmonology Reports1 citations
Semantic Scholar
Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis
A. Nambiar, J. Justice, T. Tchkonia, N. LeBrasseur +7 more
2019Idiopathic interstitial pneumonias1 citations
Semantic Scholar
TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN
A. Nambiar, J. Justice, R. Pascual, T. Tchkonia +4 more
2018Chest1 citations Open access
Semantic Scholar
Longitudinal Changes In The Composite Physiologic Index And Pulmonary Function In Patients With Idiopathic Pulmonary Fibrosis And Emphysema
S. Schmidt, Baskaran Sundaram, N. Tayob, Mei-Lan K. Han +10 more
2010Asian Test Symposium1 citations
Semantic Scholar
PS5-06-02: Cdk4/6 inhibitor-induced interstitial lung disease: a rare but severe complication in breast cancer treatment
S. Haddad, D. Portillo, A. Nambiar, M. Kim +3 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Monthly pulse methylprednisolone infusions in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases: a single-center retrospective analyses
Dean Kellogg, Jay Peters, Jesse Sherratt, S. Ocrospoma-Heraud +2 more
2025Therapeutic Advances in Respiratory Disease0 citations Open access
Semantic Scholar
Comparison of MDD across two different ILD referral centers using the same CRF
F. Amati, Dean L. Kellogg, Marcos I. Restrepo, F. Blasi +4 more
2024ILD/DPLD of known origin0 citations
Semantic Scholar
Ingested Denture as an Esophageal Foreign Body
Ariadna Perez-Sanchez, Riya N Soni, Aristides Armas-Villalba, A. Nambiar +1 more
2024Annals of Internal Medicine: Clinical Cases0 citations Open access
Semantic Scholar
Diagnostic and prognostic trajectories of ILDs after the MDD
F. Amati, Dean L. Kellogg, Marcos I. Restrepo, F. Blasi +2 more
2024Idiopathic interstitial pneumonias0 citations
Semantic Scholar
PREDICTORS OF NONRESPONSE TO IMMUNOSUPPRESSANTS IN NON-IPF ILD: A SINGLE-CENTER RETROSPECTIVE STUDY
Sergio Vallejo, S. Ocrospoma-Heraud, Dean Kellogg, Fatima Dollar +2 more
2024Chest0 citations
Semantic Scholar
NOVEL USE OF MONTHLY PULSE METHYLPREDNISOLONE INFUSIONS IN PATIENTS WITH NON-IPF ILD: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
Fatima Dollar, Dean Kellogg, A. Nambiar, Jay I. Peters +1 more
2023Chest0 citations Open access
Semantic Scholar
A LOW FVC/DLCO RATIO HELPS INCREASE CLINICAL SUSPICION FOR FIBROTIC HP OVER IPF
T.S. Vongvivitpatana, A. Nambiar
2023Chest0 citations
Semantic Scholar
Perceptions of Pulmonary Fibrosis Foundation Care Center Network Providers Caring for Rural Patients With Interstitial Lung Disease
A. M. Dedent, J. Shore, R. Bascom, J. Reichuber +6 more
2023C39. CARE AND EVALUATION OF PATIENTS WITH INTERSTITIAL LUNG DISEASE0 citations
Semantic Scholar
FVC/DLCO Ratio in Patients With Fibrotic HP Versus IPF
T. S. Vongvivitpatana, A. Nambiar
2023C39. CARE AND EVALUATION OF PATIENTS WITH INTERSTITIAL LUNG DISEASE0 citations
Semantic Scholar
Senolytics in Idiopathic Pulmonary Fibrosis: The First-in-Human Randomized Controlled Trial
T. Kellogg, A. Nambiar, J. Justice, T. Tchkonia +9 more
2022B22. EMERGING MANAGEMENT OF FIBROTIC ILDs0 citations
Semantic Scholar
No Prednisone, No Problem: Use of Solu-Medrol in ILD
J. Villalpando, J. I. Peters, A. Nambiar
20200 citations
Semantic Scholar
Nintedanib—A Potential New Therapy for Systemic Sclerosis-associated Interstitial Lung Disease
T. Kulkarni, Audrey Haywood, A. Nambiar
20200 citations Open access
Semantic Scholar
The Role of Bilateral Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis
Weng-Seng Tam, T. Islam, D. Maselli, A. Nambiar
20200 citations
Semantic Scholar
Chronic Hypersensitivity Pneumonitis: The Pulmonary 'Mask-Erader'
B. Stephens, R. Choudhury, A. Nambiar
2020A36. PERPLEXING CASES IN THE INTERSTITIUM0 citations
Semantic Scholar
EFFICACY AND SAFETY OF NINTEDANIB IN US/CANADIAN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES: FURTHER ANALYSES OF THE INBUILD TRIAL
S. Shapera, Moua Teng, A. Nambiar, L. Morrison +7 more
20200 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Tchkonia×7
Invite
T. Tchkonia — researcher profile on SciRah
J. Kirkland×7
Invite
J. Kirkland — researcher profile on SciRah
N. LeBrasseur×6
Invite
N. LeBrasseur — researcher profile on SciRah
N. Musi×6
Invite
N. Musi — researcher profile on SciRah

×6

Invite

K. Flaherty — researcher profile on SciRah

Invite

F. Amati — researcher profile on SciRah

Invite

S. Aliberti — researcher profile on SciRah

Invite

J. Justice — researcher profile on SciRah

Invite

R. Pascual — researcher profile on SciRah

S. Kritchevsky×5

Invite

S. Kritchevsky — researcher profile on SciRah

Invite

S. Schmidt — researcher profile on SciRah

Invite

M. Scholand — researcher profile on SciRah